A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Clinical trial NCT02966795 · COMPLETED

Trial details

NCT number: NCT02966795
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C Virus (HCV)

Start date: 2017-01-25
Primary completion: 2018-06-06
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.